Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Patient and disease characteristics

From: Combined Spatial and Dosimetric Recurrence Pattern Analysis in Head and Neck Squamous Cell Carcinoma Following Postoperative (Chemo)radiotherapy

Recurrence population, excluding DM only

n = 40

(%)

Age

  

Median (range), years

66.0

(23–86)

Gender

  

Female

16

(40.0)

Male

24

(60.0)

Tumor site

  

Oral Cavity

33

(82.5)

 Oral Tongue

11

(27.5)

 Buccal Mucosa

1

(2.5)

 Floor of Mouth

5

(12.5)

 Upper/Lower Alveolar Ridge and Gingiva

16

(40.0)

Oropharynx (p16-)

1

(2.5)

Hypopharynx

2

(5.0)

Larynx

4

(10)

Histologic differentiation

  

Poor

7

(17.5)

Moderate

32

(80.0)

Well

0

 

p16+

1

(2.5)

Pathological T stage

  

T1

3

(7.5)

T2

4

(10.0)

T3

10

(25.0)

T4a

22

(55.0)

T4b

1

(2.5)

Pathological N stage

  

No dissection

1

(2.5)

N0

12

(30.0)

N1

5

(12,5)

N2a

1

(2,5)

N2b

5

(12,5)

N2c

1

(2,5)

N3a

0

 

N3b

15

(37.5)

Overall stage

  

Stage I

0

 

Stage II

1

(2.5)

Stage III

5

(12.5)

Stage IVa

19

(47.5)

Stage IVb

15

(37.5)

Primary surgery margin status

  

Negative (> 5 mm)

10

(25.0)

Close (1–5 mm)

17

(42.5)

Positive

11

(27.5)

Unspecified

2

(5.0)

Depth of invasion

  

≤ 5 mm

4

(10.0)

> 5 mm ≤ 10 mm

8

(20.0)

> 10 mm

17

(42.5)

Unspecified

11

(27.5)

Perineural invasion

  

Yes

18

(45.0)

No

17

(42.5)

Unspecified

5

(12.5)

Lymphovascular invasion

  

Yes

23

(57.5)

No

17

(42.5)

Extracapsular extension

  

Yes

15

(55.5)

No

12

(44.5)